CoChat

Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties

Piątkowska, Elżbieta, Paleczny, Justyna, Dydak, Karolina, Letachowicz, Krzysztof · 2021 · PLOS ONE
Cited by 12

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Proper protection of vascular access after haemodialysis is one of the key measures for the prevention of catheter-related infections. Various substances with bactericidal and anticoagulant properties are used to fill catheters, but due to the unsatisfactory clinical effects and occurrence of adverse reactions, the search for new substances is still ongoing. In the present paper, we compared the in vitro antimicrobial activity of solutions used for tunnelled catheter locking (taurolidine, trisodium citrate) and solutions of substances that could potentially be used for this purpose (sodium bicarbonate, polyhexanide-betaine). The studies have been conducted on bacteria that most commonly cause catheter-related infections. The values of both minimum inhibitory concentration and minimum biofilm eradication concentration of the substances were determined. The ability of the tested substances to eradicate biofilm from the dialysis catheter surface was also evaluated. The results showed that polyhexanide-betaine inhibited the growth of all microbes comparably to taurolidine, even after ≥ 32-fold dilution. The activity of trisodium citrate and sodium bicarbonate was significantly lower. Polyhexanide exhibited the highest activity in the eradication of bacterial biofilm on polystyrene plates. The biofilm formed on a polyurethane dialysis catheter was resistant to complete eradication by the test substances. Polyhexanide-betaine and taurolidine showed the highest activity. Inhibition of bacterial growth regardless of species was observed not only at the highest concentration of these compounds but also after dilution 32–128x (taurolidine) and 32–1024x (polyhexanide-betaine). Therefore, it can be assumed that taurolidine application as a locking solution prevents catheter colonization and systemic infection development. Taurolidine displays high antimicrobial efficacy against Gram-positive cocci as well as Gram-negative bacilli. On the contrary, the lowest antibacterial effect displayed product contained sodium bicarbonate. The inhibitions of bacterial growth were not satisfactory to consider it as a substance for colonization prevention. Polyhexanidine-betaine possessed potent inhibitory and biofilm eradication properties comparing to all tested products. PHMB is applied as a wound irrigation solution worldwide. However, based on our results, we assume that the PHMB is a promising substance for catheter locking solutions thanks to its safety and high antimicrobial properties.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0258148

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 54

  1. M Brala, 2014, Long-term complications after hemodialysis catheter implantation, Geriatria, 8, 179
  2. N Gunawansa, 2018, Hemodialysis catheter-related central venous thrombosis: clinical approach to evaluation and management, Ann Vasc Surg, 51, 298, 10.1016/j.avsg.2018.02.033 · DOI
  3. M Suzuki, 2016, Bacteremia in hemodialysis patients, World J Nephrol, 5, 489, 10.5527/wjn.v5.i6.489 · DOI
  4. Y Gil Giraldo, 2020, Vascular access-related mortality in hemodialysis patients during and after hospitalization., Ther Apher Dial.
  5. D Santoro, 2014, Vascular access for hemodialysis: current perspectives, Int J Nephrol Renovasc Dis, 8, 281, 10.2147/IJNRD.S46643 · DOI · Paper page
  6. RA Reitzel, 2019, Epidemiology of infectious and noninfectious catheter complications in patients receiving home parenteral nutrition: a systematic review and meta-analysis, J Parenteral and Enteral Nutr, 43, 832, 10.1002/jpen.1609 · DOI
  7. S Mandolfo, 2019, Cost analysis of haemodialysis catheter related bloodstream infection through the DRG system, "on behalf of Project Group of Vascular Access of Italian Society of Nephrology"., G Ital Nefrol, 36
  8. W Winnicki, 2018, Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters, Kidney International, 93, 753, 10.1016/j.kint.2017.06.026 · DOI
  9. TNV Bueloni, 2019, Cefazolin-gentamicin versus taurolidine-citrate for the prevention of infection in tunneled central catheters in hemodialysis patients: A quasi-experimental trial, Int J Infect Dis, 85, 16, 10.1016/j.ijid.2019.05.017 · doi:10.1016/j.ijid.2019.05.017
  10. H Van Der Meersch, 2014, Hemodialysis catheter design and catheter performance: a randomized controlled trial, Am J Kidney Dis, 64, 902, 10.1053/j.ajkd.2014.02.017 · DOI
  11. DB Nguyen, 2017, National Healthcare Safety Network (NHSN) dialysis event surveillance report for 2014., Clin J Am Soc Nephrol, 12, 1139, 10.2215/CJN.11411116 · DOI · Paper page
  12. R Venkataraman, 2018, Multicenter observational study to evaluate epidemiology and resistance patterns of common intensive care unit-infections, Indian J Crit Care Med, 22, 20, 10.4103/ijccm.IJCCM_394_17 · DOI
  13. EMC D’Agata, 2018, Addressing the problem of multidrug-resistant organisms in dialysis, Clin J Am Soc Nephrol, 13, 666, 10.2215/CJN.13781217 · doi:10.2215/cjn.13781217
  14. L Golestaneh, 2018, Prevention of hemodialysis catheter infections: ointments, dressings, locks and catheter hub devices, Hemodialysis International, 22, 575, 10.1111/hdi.12703 · DOI
  15. CY Yang, 2020, Hemodialysis vascular access care during the COVID-19 pandemic., J Chin Med Assoc, 83, 634, 10.1097/JCMA.0000000000000348 · DOI
  16. W Bryzik-Wechowska, 2012, Zastosowanie roztworu taurolidyny z heparyną do zamykania cewników tunelizowanych w profilaktyce zakażeń odcewnikowych u chorych hemodializowanych, Nefrol Dial Ped, 16, 65
  17. JA Justo, 2014, Antibiotic lock therapy: review of technique and logistical challenges, Infect and Drug Resist, 12, 343
  18. KX Sheng, 2020, Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis, Clin Microbiol Infect, 26, 545, 10.1016/j.cmi.2019.12.003 · DOI
  19. DL Landry, 2010, Emergence of gentamycicn-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis, Clin J Am Soc Nephrol, 5, 1799, 10.2215/CJN.01270210 · DOI · Paper page
  20. F Al-Ali, 2018, Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study, Nephrol Dial Transplant, 33, 619, 10.1093/ndt/gfx187 · DOI
  21. S Tribler, 2017, Taurolidine-citrate-heparin lock reduces catheter-related bloodstream infections in intestinal failure patients dependent on home parenteral support: a randomized, placebo-controlled trial, Am J Clin Nutr, 106, 839, 10.3945/ajcn.117.158964 · DOI
  22. D Kamińska, 2013, Zastosowanie taurolidyny w zapobieganiu zakażeniom odcewnikowym, Stand Med Pediatr, 10, 423
  23. ED Olthof, 2015, Microbiocidal effects of various taurolidine containing catheter lock solutions, Clin Nutr, 34, 309, 10.1016/j.clnu.2014.04.023 · doi:10.1016/j.clnu.2014.04.023
  24. A Diamanti, 2014, Recurrent catheter related bloodstream infections by Candida glabrata: Successful treatment with taurolidine, Clinical Nutrition., 33, 367, 10.1016/j.clnu.2014.01.010 · doi:10.1016/j.clnu.2014.01.010
  25. DG Maki, 2011, AZEPTIC trial investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multi-center, controlled, randomized trail, Crit Care Med, 39, 613, 10.1097/CCM.0b013e318206b5a2 · DOI
  26. AS El-Hennawy, 2019, Sodium bicarbonate catheter lock solution reduces hemodialysis catheter loss due to catheter-related thrombosis and blood stream infection: an open-label clinical trial, Nephrol Dial Transplant, 34, 1739, 10.1093/ndt/gfy388 · doi:10.1093/ndt/gfy388
  27. M Núñez-Moral, 2014, Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. Results of a prospective randomized trial., Perit Dial Int, 34, 271, 10.3747/pdi.2012.00109 · doi:10.3747/pdi.2012.00109
  28. J Webster, 2017, Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial)., J Hosp Infect., 96, 223, 10.1016/j.jhin.2017.04.009 · DOI
  29. J Pannek, 2020, Tolerability and safety of urotainer® polihexanide 0.02% in catheterized patients: a prospective cohort study, BMC Urol., 20, 92, 10.1186/s12894-020-00650-1 · DOI
  30. M Ceri, 2020, Effect of Local Polyhexanide Application in Preventing Exit-Site Infection and Peritonitis: A Randomized Controlled Trial, Ther Apher Dial., 24, 81, 10.1111/1744-9987.12836 · doi:10.1111/1744-9987.12836
  31. J Machuca, 2019, Comparative activity of a polyhexanide-betaine solution against biofilms produced by multidrug-resistant bacteria belonging to high-risk clones, H Hosp Infec., 103, e92, 10.1016/j.jhin.2019.04.008 · DOI
  32. R López-Rojas, 2017, In vitro activity of a polyhexanide-betaine solution against high-risk clones of multidrug-resistant nosocomial pathogens, Enferm Infecc Microbiol Clin, 35, 12, 10.1016/j.eimc.2016.02.008 · DOI
  33. WH Fabry, 2014, Activity of the antiseptic polyhexanide against gram-negative bacteria, Microb Drug Resist, 20, 138, 10.1089/mdr.2013.0113 · doi:10.1089/mdr.2013.0113
  34. S Sowlati-Hashjin, 2020, Insights into the Polyhexamethylene Biguanide (PHMB) Mechanism of Action on Bacterial Membrane and DNA: A Molecular Dynamics Study, J Phys Chem B, 124, 4487, 10.1021/acs.jpcb.0c02609 · DOI
  35. K Kaehn, 2010, Polihexanide: a safe and highly effective biocide, Skin Pharmacol Physiol, 23, 7, 10.1159/000318237 · doi:10.1159/000318237
  36. HD Polaschegg, 2008, Catheter locking-solution spillage: theory and experimental verification, Blood Purif, 26, 255, 10.1159/000123706 · doi:10.1159/000123706
  37. HD Polaschegg, 2005, Loss of catheter locking solution caused by fluid density, ASAIO J., 51, 230, 10.1097/01.MAT.0000159742.15560.93 · doi:10.1097/01.mat.0000159742.15560.93
  38. CJ Doorenbos, 2006, remaining in central venous catheters after the interdialytic interval, Nephrology Dialysis Transplantation, 21, 543, 10.1093/ndt/gfi331 · doi:10.1093/ndt/gfi331
  39. Y Sun, 2020, Taurolidine lock solution for catheter-related bloodstream infections in pediatric patients: A meta-analysis, PLoS One, 15, e0231110, 10.1371/journal.pone.0231110 · DOI
  40. Y Liu, 2013, 8, e79417
  41. M Arnoriaga Rodríguez, 2018, Clinical and economic impact of the taurolidine lock on home parenteral nutrition, Nutr Hosp, 35, 761
  42. Y Wouters, 2018, Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition, Aliment Pharmacol Ther, 48, 410, 10.1111/apt.14904 · doi:10.1111/apt.14904
  43. LR Solomon, 2012, Observational study of need for thrombolytic therapy and incidence of bacteremia using taurolidine-citrate-heparin, taurolidine-citrate and heparin catheter locks in patients treated with hemodialysis, Semin Dial., 25, 233, 10.1111/j.1525-139X.2011.00951.x · DOI
  44. R Zwiech, 2016, A Taurolidine-Citrate-Heparin lock solution effectively eradicates pathogens from the catheter biofilm in hemodialysis patients, Am J Ther., 23, e363, 10.1097/MJT.0b013e31828d4610 · doi:10.1097/mjt.0b013e31828d4610
  45. HC Flemming, 2016, Biofilms: an emergent form of bacterial life, Nature Reviews Microbiology, 14, 563, 10.1038/nrmicro.2016.94 · DOI · Paper page
  46. I Olsen, 2015, Biofilm-specific antibiotic tolerance and resistance, Eur J Clin Microbiol Infect Dis, 34, 877, 10.1007/s10096-015-2323-z · DOI · Paper page
  47. N Venkatesan, 2015, Bacterial resistance in biofilm-associated bacteria, Future Microbiol, 10, 1743, 10.2217/fmb.15.69 · DOI · Paper page
  48. RM Shanks, 2006, Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces, Nephrol Dial Transplant, 21, 2247e55, 10.1093/ndt/gfl170 · DOI · Paper page
  49. EF Haney, 2018, Critical assessment of methods to quantify biofilm growth and evaluate antibiofilm activity of host defence peptides, Biomolecules, 8, 29, 10.3390/biom8020029 · DOI · Paper page
  50. H Koo, 2017, Targeting microbial biofilms: current and prospective therapeutic strategies, Nat Rev Microbiol, 15, 740, 10.1038/nrmicro.2017.99 · DOI · Paper page
  51. JN Anderl, 2003, Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin, Antimicrob Agents Chemother, 47, 1251, 10.1128/AAC.47.4.1251-1256.2003 · DOI · Paper page
  52. C Torres-Viera, 2000, Activities of taurolidine in vitro and in experimental enterococcal endocarditis, Antimicrob Agents Chemother, 44, 1720, 10.1128/AAC.44.6.1720-1724.2000 · DOI
  53. L Bjornson, 2018, Is it safe to re-access sodium bicarbonate bottles for use in minor surgery?, J Ped Surg, 53, 2290, 10.1016/j.jpedsurg.2018.04.005 · doi:10.1016/j.jpedsurg.2018.04.005
  54. M Heidempergher, 2021, Targeting COVID-19 prevention in hemodialysis facilities is associated with a drastic reduction in central venous catheter-related infections., J Nephrol., 34, 345, 10.1007/s40620-020-00900-3 · DOI

Metadata

Authors
Piątkowska, E., Paleczny, J., Dydak, K., & Letachowicz, K.
Venue
PLOS ONE
Published
2021-10-07
Volume
16
Issue
10
Pages
e0258148
ISSN
1932-6203
Cited by
12
References
3
Language
en
Funders
Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu (SUB.D230.21.102, SUB.D230.20.002)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.